Mayflower Financial Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
ATO
FAF
Mayflower Financial Advisors's GILD Position: Q2 2026 in Review
Mayflower Financial Advisors increased its Gilead Sciences (GILD) stake by 2% in Q2 2026, buying an estimated $16.1K and bringing the position to 6,254 shares worth $790K. The position accounts for 0.07% of the portfolio, ranked #223.
Mayflower Financial Advisors first reported a position in GILD in Q4 2020 and has held it in 15 quarters since. The position peaked at $855K in Q1 2026. 849 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Mayflower Financial Advisors held 6,254 shares of Gilead Sciences worth $790K as of Q2 2026.
- Mayflower Financial Advisors bought 122 Gilead Sciences shares in Q2 2026, an estimated $16.1K.
- Gilead Sciences made up 0.07% of Mayflower Financial Advisors's portfolio in Q2 2026, its #223 holding.
- Mayflower Financial Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 15 quarters since.
- Mayflower Financial Advisors's Gilead Sciences position peaked at $855K in Q1 2026.
- 849 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Mayflower Financial Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.